Cytokinetics Inc Sustainability Reports
Cytokinetics, Incorporated is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule therapeutics that modulate muscle function. The company develops treatments for serious diseases and medical conditions where muscle performance is compromised, such as hypertrophic cardiomyopathy and heart failure.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300BE5DY1HW7IHA64
FIGI: BBG001SGMVF2
12 reports from 2007 to 2025
